Maynard Um
-
-
-
-
-
-
-
Oruka Therapeutics expands license agreement to include IBD indication
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) PT Raised to $165 at Wedbush
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) PT Raised to $78 at BTIG
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA): 'Commercial Precedents Continue to Read Through Positively to ORKA-001/2'
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) Misses Q3 EPS by 55c
-
-
-
-
-
-
-
Barclays Starts Oruka Therapeutics (ORKA) at Overweight
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
-
443,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

